Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-13 Sale |
2021-04-14 8:24 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
6,250 | $30.98 | $193,639 | 101,951 (Direct) |
View |
| 2020-12-21 Sale |
2020-12-22 5:49 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO |
46,347 | $22.1 | $1,024,463 | 2,772 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-15 8:20 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO |
53,653 | $21.87 | $1,173,264 | 49,119 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-10 4:19 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP Chief Financial Officer |
5,000 | $25 | $125,000 | 54,463 (Direct) |
View |
| 2020-11-05 Sale |
2020-11-06 5:43 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP, CFO |
5,000 | $23 | $115,000 | 59,463 (Direct) |
View |
| 2020-10-15 Sale |
2020-10-15 6:04 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP, CFO |
15,000 | $20.03 | $300,507 | 64,463 (Direct) |
View |
| 2020-07-13 Sale |
2020-07-15 4:39 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
920 | $24.44 | $22,485 | 18,041 (Direct) |
View |
| 2020-05-20 Sale |
2020-05-20 6:59 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr.VP, Chief Financial Officer |
15,000 | $25.03 | $375,380 | 81,057 (Direct) |
View |
| 2020-05-08 Sale |
2020-05-11 6:42 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr VP, Chief Financial Officer |
15,000 | $23.14 | $347,034 | 46,057 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-19 Option Award |
2022-02-23 4:15 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
4,222 | $0 | 80,175 (Direct) |
View |
| 2021-08-23 Option Award |
2021-08-24 5:17 pm |
N/A 2031-08-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-08-11 Exercise |
2021-08-12 4:32 pm |
2017-03-01 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
15,000 | $0 | 75,953 (Direct) |
View |
| 2021-08-11 Exercise |
2021-08-12 4:32 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
15,000 | $12.98 | 75,953 (Direct) |
View |
| 2021-07-30 Option Award |
2021-07-30 4:32 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
40,000 | $0 | 1,618,916 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-14 8:24 pm |
N/A 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
6,250 | $0 | 101,951 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-14 8:24 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
6,250 | $12.98 | 101,951 (Direct) |
View |
| 2021-03-26 Other |
2021-03-30 6:23 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
10,000 | $0 | 1,598,916 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:55 pm |
N/A 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Kelly James Patrick Executive Vice-President & CFO |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:54 pm |
N/A 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:54 pm |
N/A 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
17,000 | $0 | 103,326 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:53 pm |
N/A 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP Ops. & IT |
17,000 | $0 | 23,839 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:51 pm |
N/A 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:49 pm |
N/A 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
200,000 | $0 | 1,778,916 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:49 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
11,587 | $0 | 72,540 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:48 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
11,587 | $0 | 16,798 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:47 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
11,587 | $0 | 29,628 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:46 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
11,587 | $0 | 109,096 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:46 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
11,587 | $0 | 16,798 (Direct) |
View |
Ownership |
2021-01-04 7:59 pm |
N/A 2030-02-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
0 | $0 | 15,000 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-22 5:49 pm |
N/A 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO |
46,347 | $0 | 2,772 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-22 5:49 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO |
46,347 | $12.98 | 2,772 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 8:20 pm |
N/A 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO |
53,653 | $0 | 49,119 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 8:20 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO |
3,653 | $12.98 | 49,119 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 8:20 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO |
50,000 | $9.13 | 49,119 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 4:19 pm |
N/A 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP Chief Financial Officer |
5,000 | $0 | 54,463 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 4:19 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP Chief Financial Officer |
5,000 | $12.98 | 54,463 (Direct) |
View |
| 2020-11-05 Exercise |
2020-11-06 5:43 pm |
N/A 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP, CFO |
5,000 | $0 | 59,463 (Direct) |
View |
| 2020-11-05 Exercise |
2020-11-06 5:43 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP, CFO |
5,000 | $12.98 | 59,463 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-15 6:04 pm |
N/A 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP, CFO |
15,000 | $0 | 64,463 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-15 6:04 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr. VP, CFO |
15,000 | $12.98 | 64,463 (Direct) |
View |
| 2020-10-12 Option Award |
2020-10-13 12:03 pm |
N/A 2030-10-12 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Kelly James Patrick Executive Vice-President & CFO |
135,000 | $0 | 135,000 (Direct) |
View |
| 2020-08-25 Gift |
2020-08-28 4:11 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr.VP, Chief Financial Officer |
2,120 | $0 | 44,463 (Direct) |
View |
| 2020-07-27 Option Award |
2020-07-28 4:35 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
15,625 | $0 | 1,578,916 (Direct) |
View |
| 2020-07-13 Exercise |
2020-07-15 4:39 pm |
2011-11-16 2020-11-16 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
8,750 | $0 | 18,041 (Direct) |
View |
| 2020-07-13 Exercise |
2020-07-15 4:39 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
8,750 | $2.56 | 18,041 (Direct) |
View |
| 2020-07-10 Option Award |
2020-07-13 4:05 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
15,625 | $0 | 1,563,291 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-20 6:59 pm |
N/A 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr.VP, Chief Financial Officer |
15,000 | $0 | 81,057 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-20 6:59 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr.VP, Chief Financial Officer |
15,000 | $12.98 | 81,057 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 6:42 pm |
N/A 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr VP, Chief Financial Officer |
15,000 | $0 | 46,057 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 6:42 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | PATRICK GREGORY S Sr VP, Chief Financial Officer |
15,000 | $9.13 | 46,057 (Direct) |
View |